Selected research
Industry Research
Menopause Blood Test Industry Research Report 2026
Market perspective
The global Menopause Blood Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Menopause Blood Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Menopause Blood Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Menopause Blood Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Menopause Blood Test include Thriva, MyHealthChecked, Forth, Labcorp OnDemand, Randox, Mina Health, OptimallyMe, Welzo and Quest, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Menopause Blood Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Menopause Blood Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Menopause Blood Test Market by Company
Thriva
MyHealthChecked
Forth
Labcorp OnDemand
Randox
Mina Health
OptimallyMe
Welzo
Quest
LifeCell
High Trees Clinics
Thorne HealthTech
Everlywell
ZRT Laboratory
Medichecks
Menopause Blood Test Segment by Type
Fingerstick Blood
Venous Blood
Menopause Blood Test Segment by Application
Premenopausal
Postmenopausal
Menopause Blood Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Blood Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Menopause Blood Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Blood Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Menopause Blood Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fingerstick Blood
- Venous Blood
Applications
- Premenopausal
- Postmenopausal
Companies covered
- Thriva
- MyHealthChecked
- Forth
- Labcorp OnDemand
- Randox
- Mina Health
- OptimallyMe
- Welzo
- Quest
- LifeCell
- High Trees Clinics
- Thorne HealthTech
- Everlywell
- ZRT Laboratory
- Medichecks
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Menopause Blood Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Fingerstick Blood
- 2.2.3 Venous Blood
- 2.3 Menopause Blood Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Premenopausal
- 2.3.3 Postmenopausal
- 2.4 Assumptions and Limitations
3 Menopause Blood Test Breakdown Data by Type
- 3.1 Global Menopause Blood Test Historic Market Size by Type (2021-2026)
- 3.2 Global Menopause Blood Test Forecasted Market Size by Type (2027-2032)
4 Menopause Blood Test Breakdown Data by Application
- 4.1 Global Menopause Blood Test Historic Market Size by Application (2021-2026)
- 4.2 Global Menopause Blood Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Menopause Blood Test Market Perspective (2021-2032)
- 5.2 Global Menopause Blood Test Growth Trends by Region
- 5.2.1 Global Menopause Blood Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Menopause Blood Test Historic Market Size by Region (2021-2026)
- 5.2.3 Menopause Blood Test Forecasted Market Size by Region (2027-2032)
- 5.3 Menopause Blood Test Market Dynamics
- 5.3.1 Menopause Blood Test Industry Trends
- 5.3.2 Menopause Blood Test Market Drivers
- 5.3.3 Menopause Blood Test Market Challenges
- 5.3.4 Menopause Blood Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Menopause Blood Test Players by Revenue
- 6.1.1 Global Top Menopause Blood Test Players by Revenue (2021-2026)
- 6.1.2 Global Menopause Blood Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Menopause Blood Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Menopause Blood Test Head Office and Area Served
- 6.4 Global Menopause Blood Test Players, Product Type & Application
- 6.5 Global Menopause Blood Test Manufacturers Established Date
- 6.6 Global Menopause Blood Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Menopause Blood Test Market Size (2021-2032)
- 7.2 North America Menopause Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Menopause Blood Test Market Size by Country (2021-2026)
- 7.4 North America Menopause Blood Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Menopause Blood Test Market Size (2021-2032)
- 8.2 Europe Menopause Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Menopause Blood Test Market Size by Country (2021-2026)
- 8.4 Europe Menopause Blood Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Menopause Blood Test Market Size (2021-2032)
- 9.2 Asia-Pacific Menopause Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Menopause Blood Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Menopause Blood Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Menopause Blood Test Market Size (2021-2032)
- 10.2 South America Menopause Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Menopause Blood Test Market Size by Country (2021-2026)
- 10.4 South America Menopause Blood Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Menopause Blood Test Market Size (2021-2032)
- 11.2 Middle East & Africa Menopause Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Menopause Blood Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Menopause Blood Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thriva
- 12.1.1 Thriva Company Information
- 12.1.2 Thriva Business Overview
- 12.1.3 Thriva Revenue in Menopause Blood Test Business (2021-2026)
- 12.1.4 Thriva Menopause Blood Test Product Portfolio
- 12.1.5 Thriva Recent Developments
- 12.2 MyHealthChecked
- 12.2.1 MyHealthChecked Company Information
- 12.2.2 MyHealthChecked Business Overview
- 12.2.3 MyHealthChecked Revenue in Menopause Blood Test Business (2021-2026)
- 12.2.4 MyHealthChecked Menopause Blood Test Product Portfolio
- 12.2.5 MyHealthChecked Recent Developments
- 12.3 Forth
- 12.3.1 Forth Company Information
- 12.3.2 Forth Business Overview
- 12.3.3 Forth Revenue in Menopause Blood Test Business (2021-2026)
- 12.3.4 Forth Menopause Blood Test Product Portfolio
- 12.3.5 Forth Recent Developments
- 12.4 Labcorp OnDemand
- 12.4.1 Labcorp OnDemand Company Information
- 12.4.2 Labcorp OnDemand Business Overview
- 12.4.3 Labcorp OnDemand Revenue in Menopause Blood Test Business (2021-2026)
- 12.4.4 Labcorp OnDemand Menopause Blood Test Product Portfolio
- 12.4.5 Labcorp OnDemand Recent Developments
- 12.5 Randox
- 12.5.1 Randox Company Information
- 12.5.2 Randox Business Overview
- 12.5.3 Randox Revenue in Menopause Blood Test Business (2021-2026)
- 12.5.4 Randox Menopause Blood Test Product Portfolio
- 12.5.5 Randox Recent Developments
- 12.6 Mina Health
- 12.6.1 Mina Health Company Information
- 12.6.2 Mina Health Business Overview
- 12.6.3 Mina Health Revenue in Menopause Blood Test Business (2021-2026)
- 12.6.4 Mina Health Menopause Blood Test Product Portfolio
- 12.6.5 Mina Health Recent Developments
- 12.7 OptimallyMe
- 12.7.1 OptimallyMe Company Information
- 12.7.2 OptimallyMe Business Overview
- 12.7.3 OptimallyMe Revenue in Menopause Blood Test Business (2021-2026)
- 12.7.4 OptimallyMe Menopause Blood Test Product Portfolio
- 12.7.5 OptimallyMe Recent Developments
- 12.8 Welzo
- 12.8.1 Welzo Company Information
- 12.8.2 Welzo Business Overview
- 12.8.3 Welzo Revenue in Menopause Blood Test Business (2021-2026)
- 12.8.4 Welzo Menopause Blood Test Product Portfolio
- 12.8.5 Welzo Recent Developments
- 12.9 Quest
- 12.9.1 Quest Company Information
- 12.9.2 Quest Business Overview
- 12.9.3 Quest Revenue in Menopause Blood Test Business (2021-2026)
- 12.9.4 Quest Menopause Blood Test Product Portfolio
- 12.9.5 Quest Recent Developments
- 12.10 LifeCell
- 12.10.1 LifeCell Company Information
- 12.10.2 LifeCell Business Overview
- 12.10.3 LifeCell Revenue in Menopause Blood Test Business (2021-2026)
- 12.10.4 LifeCell Menopause Blood Test Product Portfolio
- 12.10.5 LifeCell Recent Developments
- 12.11 High Trees Clinics
- 12.11.1 High Trees Clinics Company Information
- 12.11.2 High Trees Clinics Business Overview
- 12.11.3 High Trees Clinics Revenue in Menopause Blood Test Business (2021-2026)
- 12.11.4 High Trees Clinics Menopause Blood Test Product Portfolio
- 12.11.5 High Trees Clinics Recent Developments
- 12.12 Thorne HealthTech
- 12.12.1 Thorne HealthTech Company Information
- 12.12.2 Thorne HealthTech Business Overview
- 12.12.3 Thorne HealthTech Revenue in Menopause Blood Test Business (2021-2026)
- 12.12.4 Thorne HealthTech Menopause Blood Test Product Portfolio
- 12.12.5 Thorne HealthTech Recent Developments
- 12.13 Everlywell
- 12.13.1 Everlywell Company Information
- 12.13.2 Everlywell Business Overview
- 12.13.3 Everlywell Revenue in Menopause Blood Test Business (2021-2026)
- 12.13.4 Everlywell Menopause Blood Test Product Portfolio
- 12.13.5 Everlywell Recent Developments
- 12.14 ZRT Laboratory
- 12.14.1 ZRT Laboratory Company Information
- 12.14.2 ZRT Laboratory Business Overview
- 12.14.3 ZRT Laboratory Revenue in Menopause Blood Test Business (2021-2026)
- 12.14.4 ZRT Laboratory Menopause Blood Test Product Portfolio
- 12.14.5 ZRT Laboratory Recent Developments
- 12.15 Medichecks
- 12.15.1 Medichecks Company Information
- 12.15.2 Medichecks Business Overview
- 12.15.3 Medichecks Revenue in Menopause Blood Test Business (2021-2026)
- 12.15.4 Medichecks Menopause Blood Test Product Portfolio
- 12.15.5 Medichecks Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst